Background: Prognosis of pneumococcal meningitis (PM) remains very poor, especially in less developed countries. Currently, few multi-centric studies on pediatric PM have been reported in mainland China. Objectives: This study aimed to explore the correlation of clinical and laboratory findings with complications and prognosis in pediatric PM. Methods: The pediatric PM patients were retrospectively recruited from ten pediatric tertiary hospitals across China between January 2013 and June 2018. Clinical, biochemical, and microbiological data and follow-up information were collected. Predictive factors for complications and prognostic factors for overall survival (OS) and sequelae-free survival (SFS) were analyzed. Results: A total of 132 pediatric PM patients were included. Seventy-one patients had complications, 25 patients died, and 39 patients had neurological sequelae. Multivariate logistic regression suggested that age less than 28 months (adjusted OR=2.654, 95% CI=1.067-6.600, P=0.036) and lower white blood cells in blood (aOR=3.169, 95% CI=1.395-7.202, P=0.006) were associated with high risk of complications. Multivariate Cox's proportional hazard regression suggested that age less than 28 months (aHR=6.479, 95%CI=1.153-36.404, P=0.034), coma (aHR=9.808, 95%CI=2.802-34.323, P=0.000), and non-adjuvant steroid therapy (aHR=4.768 95%CI=1.946-11.678, P=0.001) were independent prognostic factors for poor OS; coma (aHR=5.841, 95%CI=2.652-12.864, P=0.000), septic shock on admission (aHR=2.949, 95%CI=1.049-8.290, P=0.040), and lower glucose level in cerebrospinal fluid (CSF) (aHR=2.523, 95%CI=1.336-4.765, P=0.004) were independent prognostic factors for poor SFS. Conclusion: Age, coma, and adjuvant steroid therapy were independent factors for OS, while coma, septic shock on admission, and lower glucose level in CSF were independent factors for SFS in pediatric PM patients. These factors might be used to identify PM patients with poor prognosis and guide individual treatment.
Introduction
Streptococcus pneumoniae is a common cause of meningitis and pneumococcal meningitis (PM) accounts for 50% of bacterial meningitis globally. 1, 2 PM is also a common bacterial meningitis in China. 3 Most PM patients present with a headache, neck stiffness, and fever. 4 Culture of cerebrospinal fluid (CSF) obtained from a lumbar puncture should be performed to confirm the diagnosis of PM.
In spite of progress in diagnosis, antibiotic therapy strategies, and intensive care, PM is associated with a mortality rate of 6%-17% in high-income countries including US and some European countries. [5] [6] [7] [8] However,
in developing countries and regions such as sub-Saharan Africa, the mortality of PM patients has been reported to be as high as 73%. 7, [9] [10] [11] [12] [13] Among surviving patients, 25%-63% suffer from long-term neurological sequelae, 5, 9, 14, 15 which significantly affect the quality of life of survivors.
Early identification of patients with poor prognosis contributes to individualized treatment and more aggressive therapeutic strategies. A series of clinical features, biochemical, and microbiological factors have been identified as prognostic factors in PM. The most important prognostic factors associated with mortality of PM patients include C-reactive protein, 5 age, 16, 17 score on SOFA, Glasgow Score, severe hypoglycorrhachia, 17 corticosteroid treatment, 18 and glucose in CSF. 19 And the most important prognostic factors in relation to neurological handicaps seem to be hypoglycorrhachia, [20] [21] [22] [23] [24] shock, coma and convulsions on admission or during hospitalization, 25 mechanical ventilation requirement, late diagnosis, ataxia, and steroid treatment. 26 However, these studies are mainly performed in European and American countries and limited to a few research centers. Further multicenter research is required to verify the prognostic value of these factors and improve clinical management of PM patients in mainland China. The present study aimed to recruit pediatric PM patients retrospectively from multiple hospitals in mainland China and investigate the risk factors of complications as well as the prognostic factors of overall survival (OS) and neurological sequelae-free survival (SFS) in pediatric PM patients.
Methods Participants
A multicenter retrospective study was performed to consecutively recruit pediatric PM patients between January 2013 to June 2018 from ten pediatric tertiary hospitals in eight regions in mainland China (Shanghai, Hangzhou, Wenzhou, Xi'an, Chongqing, Shenzhen, Shandong, and Kaifeng). 
Patient inclusion and exclusion criteria

Data collection
Case record forms were used to collect data of patients' history, symptoms and signs, laboratory and microbiological findings, clinical course, complications in hospital, vaccination status, treatment, clinical outcome, neurological deficits at discharge, and follow-up visits from the ten hospitals listed in the affiliations. Underlying predisposing factors, including asplenia, history of head trauma or neurosurgery in the past 3 months, anatomical or infectious otorhinolaryngologic disorders, and immunocompromised status, were recorded. Patients with an altered immune status owing to the use of immunosuppressive drugs or splenectomy, diabetes mellitus were considered immunocompromised. Consciousness of the patients was accessed by Glasgow Coma Scale and grouped into normal, decline in consciousness, and coma.
Follow-up
PM patients were followed-up every month in the first year, and every 6 months thereafter. The last 
Results
Baseline clinical characteristics
Data from one hundred and sixty-one pediatric patients diagnosed with PM were collected from ten pediatric tertiary hospitals across China. Twenty-nine patients were excluded due to primary or secondary immunodeficiency, or age more than 5 years and 132 patients were finally included ( Figure 1 ). As shown in Table 1 , of the 132 patients, 88 were male and 44 were female. The median age of the patients was 13 months.
Lumbar puncture was performed in all patients. Seventy-sixcases had a positive CSF culture for S. pneumoniae, 31 cases had a positive blood culture for S. pneumoniae with a positive DNA testing of S. pneumoniae in CSF, and 25 cases had both positive CSF culture and positive blood culture for S. pneumoniae. All patients had signs of meningitis. An amount of 25.8% (34/132) of patients had predisposing factors for PM including cerebral trauma in eleven (8.3%), CSF leakage in 13 (9.8%), history of meningitis (ie, the patient had meningitis previously) in six (4.5%), intracranial structure malformation in five (3.8%), history of intracranial surgery in four (3.0%), and craniotomy in four (3.0%) ( Table 1 ). Eighty-four PM patients were combined with other concomitant diseases including pneumoniae, mastoiditis, sinusitis, otitis, and ear or intracranial abnormalities. Fever and vomiting were the most frequent symptoms and signs on admission (97.7% and 60.6%, respectively). The consciousness status was altered in 46 patients on admission, of which 20 (15.2%) were in a coma.
Laboratory examination results were collected from medical records before or at admission. The medians of WBC counts, protein level in CSF, and glucose level in CSF were 14. 
Complications and follow-up
PM complications were found in 53.8% (71/132) of patients by cranial CT and MRI ( (Table 4) .
Associations of clinical findings and laboratory parameters with accumulating OS
Kaplan-Meier plot curves and univariate Cox's proportional hazard regression were used to investigate the associations of clinical findings and laboratory parameters with accumulating OS and the results suggested that female sex, age less than 28 months (Figure 2A ), coma ( Figure 2B ), convulsions on admission, respiratory failure, multiple organ dysfunction syndrome (MODS) (omit RF), ventilation, septic shock, non-adjuvant steroid therapy ( Figure 2C) , and higher protein level in CSF were associated with shorter OS in pediatric PM patients ( 
Correlation of clinical findings and laboratory parameters with accumulating SFS
Associations of clinical findings and laboratory parameters with accumulating SFS were also explored. The Kaplan-Meier curves and univariate Cox's proportional hazard regression suggested that coma ( Figure 3A) , convulsions on admission, respiratory failure, MODS (omit RF), mechanical ventilation, septic shock on admission ( Figure 3B ), non-adjuvant steroid therapy, and lower glucose level in CSF ( Figure 3C ) were associated with shorter SFS (Table 6 ). After adjusting the confounding factors, coma (aHR=5.841, 95% CI=2.652-12.864, P=0.000), septic shock on admission (aHR=2.949, 95%CI=1.049-8.290, P=0.040), and lower glucose level in CSF (aHR=2.523, 95%CI=1.336-4.765, P=0.004) were found to be independent prognostic factors for unfavorable SFS in multivariate analyses (Table 6 ).
Discussion
In the present multicenter study, we included 132 pediatric patients and revealed that the overall mortality of these patients was 18.9% and the rate of focal neurological sequelae 36.4%, which were higher than that observed in US or European populations. [5] [6] [7] [8] 17, 25, 27, 28 A meta-analysis in 1993, including mainly US and European cohorts, revealed a mortality rate of 4.8%-8.1% and a neurological handicap rate of 16%-26% in pediatric PM patients. 29 Another meta-analysis in 2014, performed in Latin American and Caribbean populations, suggested that the mortality rate of pediatric PM patents was 8.3%. 30 In developing countries and regions such as sub-Saharan Africa, the mortality of PM patients has been reported to be as high as 73%. 7,9-13 The mortality of pediatric PM patients in China was higher than US or European cohorts but lower than African cohorts. The higher mortality and neurological sequelae rates emphasized the need to identify early prognostic factors for pediatric PM patients. Of the 132 pediatric PM patients in the study, meningitis-associated intracranial complications were found in 53.8% patients by cranial CT or MRI. The most common intracranial complications were subdural effusion, cerebritis, cerebral edema, and hydrocephalus. The prevalence of cerebritis and hydrocephalus in our study was higher than adult PM patients in previous study of. 31 The prevalence of concomitant diseases was 63.6% in our study and was similar to the results of previous reports. [31] [32] [33] [34] After multivariate analyses of the prognostic factors in predicting complications, OS, and SFS outcomes in pediatric PM patients, we identified that age less than 28 months was associated with complications (aOR=2.654, 95%CI=1.067-6.600, P=0.036) and short OS (aHR=6.479, 95%CI=1.153-36.404, P=0.034), coma on admission was associated with short OS (aHR=9.808, 95%CI=2.802-34.323, P=0.000) and SFS (aHR=5.841, 95%CI=2.652-12.864, P=0.000), non-adjuvant steroid therapy was associated with short OS (aHR=4.768 95%CI=1.946-11.678, P=0.001), and septic shock on admission was associated with poor SFS (aHR=2.949, 95%CI=1.049-8.290, P=0.040). Our results were similar to previous reports. 16, 17, 25, 26 According to previous evidence, the CSF of PM patients usually shows aberrant WBC count, protein level, and glucose level, thus we also analyzed the prognostic value of WBCs in blood or CSF, protein in CSF, and glucose in CSF to predict complications, OS, and SFS in pediatric PM patients. Our result suggested that lower WBCs in blood was an independent predictive factor of complications and lower glucose level in CSF was an independent prognostic factor of poor SFS. Leukopenia is reflective of severe sepsis, and lower peripheral blood and CSF WBC counts may indicate inadequacy of the immune response. Chao et al also found an association between lower WBCs in CSF and higher mortality in PM. 19 Lower glucose levels in the CSF is correlated with increased inflammation and cytokine levels 35 and the inflammatory response is implicated in the pathogenesis of PM and associated brain injury and neuronal death, via releasing potentially cytotoxic agents such as ROS and proteolytic enzymes by leucocytes recruited during the inflammatory response. 36 A lower glucose level in CSF can indicate increased central nervous system inflammation, which is expected to result in a higher risk of neurological sequelae and poor SFS in PM patients. High protein levels in CSF are related to more severe inflammatory reactions and immune responses during bacterial meningitis, 37, 38 and may also be a predictor of later poor outcomes in PM patients, although we only observed an association between protein level in CSF and OS in univariate analysis. This study is the most comprehensive nationwide, multi-centric study on pediatric PM in mainland China up to date. However, some limitations still existed in our study. Firstly, information on capsular serotyping of the pediatric PM patients in our retrospective study was not available and the associations of serotype distribution with clinical outcomes of the patients were not clear. Secondly, although pneumococcal vaccines have been licensed in mainland China, none of the patients in our study received pneumococcal vaccination, which might also be associated with prognosis in PM patients.
Conclusion
Our study showed that PM is a disease with high mortality and neurological sequelae in pediatric patients, and complications during the clinical course occur frequently. In pediatric PM patients, age less than 28 months and lower WBCs in blood were independent predictive factors for complications; age less than 28 months, coma, and non-adjuvant steroid therapy were independent prognostic factors for poor OS; and coma, septic shock on admission, and lower glucose level in CSF were independent prognostic factors for poor SFS. 
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